|
Volumn 44, Issue 3, 2000, Pages 256-267
|
Development of DNA-based radiopharmaceuticals carrying Auger-electron emitters for anti-gene radiotherapy
a a a a |
Author keywords
Gene therapy; Nucleic acid conformation; Nucleic acids; Radionuclide imaging; Radiopharmaceuticals; Radiotherapy
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
BROMINE 77;
DEOXYCYTIDINE TRIPHOSPHATE;
DNA;
DNA POLYMERASE;
IODINE 123;
IODINE 125;
OLIGODEOXYRIBONUCLEOTIDE;
PENTETATE INDIUM;
PLASMID DNA;
PURINE NUCLEOSIDE;
PYRIMIDINE NUCLEOSIDE;
REACTIVE OXYGEN METABOLITE;
SYNTHETIC PEPTIDE;
AUGER ELECTRON SPECTROSCOPY;
CANCER;
CELLULAR DISTRIBUTION;
DNA DAMAGE;
DNA REPAIR;
DNA SEQUENCE;
DRUG BINDING;
DRUG DELIVERY SYSTEM;
DRUG HALF LIFE;
DRUG SPECIFICITY;
DRUG TARGETING;
GENE DELETION;
GENE THERAPY;
HUMAN;
MULTIDRUG RESISTANCE;
NUCLEIC ACID STRUCTURE;
PHARMACEUTICAL ENGINEERING;
PLASMID;
RADIATION DOSE;
RADIATION DOSE DISTRIBUTION;
RADIATION INJURY;
RADIATION INJURY REPAIR;
RADIOISOTOPE DECAY;
REVIEW;
TRIPLE HELIX;
ANIMAL;
DNA;
DNA DAMAGE;
DNA REPAIR;
HUMAN;
IODINE RADIOISOTOPES;
NEOPLASMS;
NUCLEIC ACID CONFORMATION;
OLIGONUCLEOTIDES;
RADIOPHARMACEUTICALS;
|
EID: 0033792956
PISSN: 11243937
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (29)
|
References (66)
|